Financhill
Back

Praxis Precision Medicines, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

PRAX
Praxis Precision Medicines, Inc.

Last Price:
$330.62
Seasonality Move:
-43%

7 Day Trial

ALL ACCESS PASS

$ 7

Praxis Precision Medicines, Inc. Stock Forecast

  • Over the next 52 weeks, Praxis Precision Medicines, Inc. has on average historically risen by 58.5% based on the past 5 years of stock performance.
  • Praxis Precision Medicines, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Praxis Precision Medicines, Inc. Stock Undervalued?
    The current Praxis Precision Medicines, Inc. [PRAX] share price is $336.75. The Score for PRAX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PRAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Praxis Precision Medicines, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Praxis Precision Medicines, Inc. has on average historically risen by 58.5% based on the past 5 years of stock performance.

Praxis Precision Medicines, Inc. Stock Rating

Sell
48
Praxis Precision Medicines, Inc. (PRAX) is a Sell

Is Praxis Precision Medicines, Inc. overpriced?

  • Praxis Precision Medicines, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Praxis Precision Medicines, Inc. Stock Price History

Is PRAX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
praxismedicines.com

52-Week Data

52-Week High:
356.00
52-Week Low:
26.70

Prediction Charts

Market Cap:
8.4B
Price in USD:
336.75
Volume:
363.4K
Beta:
2.77

Technical Analysis

SMA50:
305.11
SMA100:
239.33
SMA200:
142.76
52-Wk Change:
417.84%

Stock Predictions

  • Is Praxis Precision Medicines, Inc. stock public?
    Yes, Praxis Precision Medicines, Inc. is a publicly traded company.
  • What is the Praxis Precision Medicines, Inc. stock quote today?
    The Praxis Precision Medicines, Inc. stock price is 336.75 USD today.
  • How to buy Praxis Precision Medicines, Inc. stock online?
    You can buy Praxis Precision Medicines, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-9 317.73 319.54 328.60 310.53
Feb-10 325.40 320.48 326.88 315.42
Feb-11 321.83 323.29 324.79 302.00
Feb-12 323.99 332.92 335.75 317.83
Feb-13 332.74 317.25 333.53 315.42
Feb-17 315.22 328.04 330.09 314.35
Feb-18 329.25 328.93 334.61 326.57
Feb-19 315.00 331.61 333.84 293.01
Feb-20 332.52 335.28 349.32 314.39
Feb-23 335.00 342.46 348.67 332.31
Feb-24 345.48 342.71 356.00 338.81
Feb-25 343.40 347.55 354.43 341.00
Feb-26 347.55 340.47 354.87 334.76
Feb-27 334.93 336.75 341.16 331.53

Praxis Precision Medicines, Inc. Earnings

Praxis Precision Medicines, Inc. Earnings Report: Per Share Praxis Precision Medicines, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Praxis Precision Medicines, Inc. Forecast Revenue Growth

Praxis Precision Medicines, Inc. Stock Analysis: Historical quarterly revenues per share for Praxis Precision Medicines, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.60 per share, a decrease next quarter of $0.08 per share, a decrease this year of $2.11 per share, and an increase next year of $6.57 per share.

* Praxis Precision Medicines, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.